Full-Time

Account Manager

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$109k - $154k/yr

Peabody, MA, USA

Hybrid

Three days on-site per week required.

Bachelor's, Master's

Category
Sales & Account Management (1)
Required Skills
Salesforce

Get referred to Cell Signaling Technology

See people who can refer or advise you

Requirements
  • Bachelor’s degree in Life Sciences or a related field
  • 2+ years of experience in technical sales, field support, or inside sales in the life science industry
  • Practical experience with common antibody applications (e.g., IHC, Flow Cytometry, ELISAs, High Content Imaging)
  • A functional understanding of academic research workflows, grant funding cycles and foundational discovery science
  • Proven ability to manage complex sales environments and build long-term customer relationships across various university departments
  • Excellent communication, presentation, and time management skills
  • Computer proficiency including Microsoft Office and CRM systems like Salesforce.com
  • Ability to work a hybrid schedule (minimum 3 days/week in the office) and travel as necessary within the assigned territory, with occasional domestic travel for conferences and sales trainings and meetings
Responsibilities
  • Achieve quarterly sales goals within an assigned territory.
  • Focus on promoting core products and executing defined sales campaigns tailored to university research workflows.
  • Navigate university purchasing systems, institutional contracts, and grant-funded procurement cycles.
  • Accurately log all sales activity and opportunities in the CRM.
  • Establish and maintain relationships with technical end-users (bench scientists, postdocs, graduate students), Principal Investigators (PIs), and academic procurement contacts.
  • Build strong partnerships with university shared resource facilities and core laboratories (e.g., flow cytometry cores, imaging cores) to explore institutional volume opportunities.
  • Act as a trusted advisor, ensuring exceptional customer experience through proactive communication and solution-oriented selling that aligns with academic research goals.
  • Partner with Sales, Product Management, Marketing, R&D to deliver high-impact engagement.
  • Provide customer feedback and trends to internal teams to support product innovation and service improvement.
  • Coordinate with technical/application scientists to address complex academic workflow needs and provide robust scientific support.
  • Gather and share market intelligence on academic research trends, Government, Private and Philanthropic grant organization funding directions, competitive activity, and emerging scientific needs.
  • Identify new business opportunities within university systems and inform commercial strategy.
  • Participate in local scientific conferences, university vendor shows, symposia, and customer meetings to stay ahead of industry trends.
  • Maintain accurate records, pricing agreements, and account documentation.
  • Ensure compliance with university purchasing guidelines, contractual obligations and ethical sales practices.
  • Manage expense budgets and submit timely reports
Desired Qualifications
  • Master’s degree in Life Science or related fields or equivalent hands-on academic research experience
  • Experience selling to or supporting academic, higher education or government research accounts
  • Familiarity with university procurement processes, e-procurement platforms and institutional buying groups
  • Demonstrated success in high-value solution and services selling or supporting academic research
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quantum-Si and CST partnered June 2026 to validate PTM analysis on Proteus.
  • CST and MJFF are developing Parkinson's antibodies, expanding disease-targeted reagent demand.
  • Nordic Biosite began exclusive Nordic distribution for CST G4S Linker antibodies in August 2026.

What critics are saying

  • CST sells research-use-only reagents; a single validation miss destroys trust fast.
  • Spatial-biology rivals compress CST's mid-plex advantage as panels standardize.
  • If citation leadership fades, CST's antibody brand moat collapses and pricing power erodes.

What makes Cell Signaling Technology unique

  • CST remains scientist-owned and runs a 600-plus employee antibody platform from Danvers.
  • CiteAb named CST 2026 Phospho Antibody Supplier of the Year.
  • CST pairs validated antibodies with SignalStar multiplex IHC and PTM analysis partnerships.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

27%

2 year growth

27%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.